Search published articles


Showing 3 results for Prostate Cancer

Mahin Farahmand, Amir Almasi-Hashiani, Davood Mehrabani,
Volume 15, Issue 10 (3-2013)
Abstract

Background: Prostate cancer is one of the most common cancers in men which its incidence rate and associated mortality and morbidity are on the rise. The aim of this study was to investigate the epidemiology of prostate cancer in Fars province between 2003 and 2008 years. Materials and Methods: In this epidemiological study, using Fars province cancer registry data, the incidence rates were calculated per 100,000 people and age standardized incidence rate (ASR) was measured by direct method using the world standard population. Data were analyzed by SPSS, version 16, and Microsoft Excel, version 2007. Cochrane Armitage Test for linear trend was used for evaluation of the incidence trend by running Winpepi software. Results: Over a 6-year period, 1212 cases were recorded in Fars province. The ASR of prostate cancer in these six years was 4.69, 7.16, 15.09, 14.04, 16.65 and 16.02, respectively, which revealed significantly increasing trends. The highest incidence rate was observed in 80 and upper age group. Conclusion: The ASR of prostate cancer in Fars province is significantly lower than other parts of the world, especially in more developed countries. This can be due to absence of screening programs and/or cancer registry.
Mahmood Reza Baghinia, Seyyed Mehdi Shariatzadeh, Neda Baghinia,
Volume 16, Issue 10 (1-2014)
Abstract

Background: Prostate cancer is one of the most prevalent type of cancer and the second cause of death among American men. Its prevalence has a direct relationship with increasing age. The present study was carried out to determine the level of prostate specific antigen (PSA) and calcium level in blood in men with prostate cancer and BPH in Arak.

Materials and Methods: In this prospective study, out of 400 Arak males, were selected from different inner-city areas through cluster sampling during a period of two years (august 2011-august 2012). After the population was approved to have the necessary criteria to be included in the study, their PSA and calcium level was measured and its mean in over 40 years. In order to determine mean difference among the seven groups T-test analysis and to determine "PSA", PSA Assay and Tandem-R kits were utilized and for measurement of serum calcium, pars azmoon kit was used.

Results: In this study, there was a markedly relationship between age and serum calcium and serum PSA in both groups.in this way that there was a negative relationship between age and serum calcium and a positive relationship between age and serum PSA.

Conclusion: With respect to the findings of the study, it could be confirmed that was a markedly relationship between serum PSA and serum calcium only in prostatic cancer patients,according to this study in future maybe we used serum calcium as a tumor-marker for screening for prostate cancer.


Bita Kaviani, Hossein Sazegar, Noosha Zia-Jahromi, Farzane Mohamadi Farsani,
Volume 20, Issue 11 (2-2018)
Abstract

Abstract
Background: The aim of this study is to investigate the role of rs137852599 single-nucleotide polymorphism in the androgen receptor coding gene on drug resistance against treatment with Enzalutamide in individuals diagnosed with prostate cancer.
Materials and Methods: In this case-control study, the ARMS-PCR analysis was conducted on androgen receptor coding gene in 50 patients diagnosed with prostate cancer with drug resistance and on 50 patients diagnosed with prostate cancer without drug resistance. The statistical analyses were performed using the GeNePop server and then the results were investigated by the SISA server.
Results: The allele frequencies of A and C alleles in rs137852599 were 0.78 and 0.22 for drug resistant and 0.94 and 0.06 for non-drug resistance groups. The results indicated that there is a meaningful relationship between drug resistance and rs137852599 single-nucleotide polymorphism
(p = 0.020).
Conclusion: The existence of single-nucleotide polymorphisms may result in drug resistance in individuals diagnosed with prostate cancer. Therefore, investigation of the existence of such polymorphisms can be effective in prescription of suitable drugs for these patients.

 


Page 1 from 1     

© 2025 CC BY-NC 4.0 | Journal of Arak University of Medical Sciences

Designed & Developed by : Yektaweb